Home  •  Project  •  Resources  •  Publications  •  Help/FAQ  •  Contact


1. Trimarchi MP, Mouangsavanh M, Huang TH, Cancer epigenetics: a perspective on the role of DNA methylation in acquired endocrine resistance, Chin J Cancer. 2011 Nov;30(11):749-56, [ 22035855 ]
2. Huang YW, Kuo CT, Stoner K, Huang TH, Wang LS, An overview of epigenetics and chemoprevention, FEBS Lett. 2011 Jul 7;585(13):2129-36. Epub 2010 Nov 5. Review, [ 21056563 ]
3. Zuo T, Liu TM, Lan X, Weng YI, Shen R, Gu F, Huang YW, Liyanarachchi S, Deatherage D, Hsu PY, Taslim C, Ramaswamy B, Shapiro CL, Lin HJ, Cheng AS, Jin V, Huang TH, Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer, Cancer Res. 2011 Mar 1;71(5):1752-62. Epub 2011 Jan 7, [ 21216892 ]
4. Huang YW, Luo J, Weng YI, Mutch DG, Goodfellow PJ, Miller DS, Huang TH, Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas, Gynecol Oncol. 2010 May;117(2):239-47. Epub 2010 Mar 7, [ 20211485 ]
5. Huang YW, Huang TH, Wang LS, Profiling DNA methylomes from microarray to genome-scale sequencing, Technol Cancer Res Treat. 2010 Apr;9(2):139-47. Review, [ 20218736 ]
6. Zuo T, Tycko B, Liu TM, Lin HJ, Huang TH, Methods in DNA methylation profiling, Epigenomics. 2009 Dec 1;1(2):331-345, [ 20526417 ]
7. Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu YW, Liu JC, Huang TH, Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer, Cancer Res. 2003 Oct 1;63(19):6178-86, [ 14559801 ]